Europe Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Application (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Endocrine, Immunology, Nutritional & Metabolic Disease, Cardiology, Mental/Behavioral Disorder, Pediatrics-specific Testing, and Others), By Technology, By Country and Growth Forecast, 2024 - 2031

The Europe Laboratory Developed Tests Market would witness market growth of 6.8% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Laboratory Developed Tests Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,465.4 million by 2031. The UK market is exhibiting a CAGR of 6.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 7.3% during (2024 - 2031).

LDTs are used to identify and characterize several infectious diseases, such as fungi, viruses, bacteria, and parasites. These tests are essential for diagnosing infectious disorders, tracking outbreaks, observing patterns in antibiotic resistance, and the direction of infection control protocols in hospital environments.

Various factors, including clinical need, technological advancements, regulatory frameworks, and market dynamics, have driven the adoption of LDTs. Healthcare providers, laboratories, and patients have increasingly recognized the value of LDTs in enhancing diagnostic accuracy, guiding treatment decisions, and improving patient outcomes. LDTs offer unique customization, flexibility, and innovation advantages compared to commercially available diagnostic tests.

The prevalence of genetic disorders in Europe drives a greater demand for genetic testing services. As per the Eurodis, an estimated 30 million people live with a rare disease in 48 European countries. 70% of patients with rare conditions seek medical attention and then wait more than a year for a definitive diagnosis. Also, the growing investment in rare diseases in Europe leads to an increased demand for specialized diagnostic testing tailored to rare disorders’ unique genetic, molecular, and clinical characteristics. As per the European Commission, the EU has extensively supported research in rare diseases through its research and innovation framework programs. Under the 7th Framework Programme and Horizon 2020, about €2.4 billion in funding has been awarded to over 440 worldwide research projects on rare disorders. Therefore, the high prevalence of rare diseases and increasing investment in research projects drive the market’s growth. 

Free Valuable Insights: The Global Laboratory Developed Tests Market will Hit USD 20.3 Billion by 2031, at a CAGR of 6.9%

Based on Application, the market is segmented into Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Endocrine, Immunology, Nutritional & Metabolic Disease, Cardiology, Mental/Behavioral Disorder, Pediatrics-specific Testing, and Others. Based on Technology, the market is segmented into Molecular Diagnostics, Immunoassays, Hematology & Coagulation, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Neogenomics, Inc.
• Guardant Health, Inc.
• Qiagen N.V
• Quest Diagnostics Incorporated
• Abbott Laboratories
• Siemens Healthineers AG (Siemens AG)
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• F.Hoffmann-La Roche Ltd.
• Eurofins Scientific SE

Europe Laboratory Developed Tests Market Report Segmentation

By Application

• Oncology
• Genetic Disorders/Inherited Disease
• Infectious & Parasitic Diseases
• Endocrine
• Immunology
• Nutritional & Metabolic Disease
• Cardiology
• Mental/Behavioral Disorder
• Pediatrics-specific Testing
• Others

By Technology

• Molecular Diagnostics
• Immunoassays
• Hematology & Coagulation
• Microbiology
• Clinical Chemistry
• Histology/Cytology
• Flow Cytometry
• Mass Spectroscopy
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Laboratory Developed Tests Market, by Application
1.4.2 Europe Laboratory Developed Tests Market, by Technology
1.4.3 Europe Laboratory Developed Tests Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Laboratory Developed Tests Market.

Chapter 5. Europe Laboratory Developed Tests Market by Application
5.1 Europe Oncology Market by Country
5.2 Europe Genetic Disorders/Inherited Disease Market by Country
5.3 Europe Infectious & Parasitic Diseases Market by Country
5.4 Europe Endocrine Market by Country
5.5 Europe Immunology Market by Country
5.6 Europe Nutritional & Metabolic Disease Market by Country
5.7 Europe Cardiology Market by Country
5.8 Europe Mental/Behavioral Disorder Market by Country
5.9 Europe Pediatrics-specific Testing Market by Country
5.1 Europe Others Market by Country

Chapter 6. Europe Laboratory Developed Tests Market by Technology
6.1 Europe Molecular Diagnostics Market by Country
6.2 Europe Immunoassays Market by Country
6.3 Europe Hematology & Coagulation Market by Country
6.4 Europe Microbiology Market by Country
6.5 Europe Clinical Chemistry Market by Country
6.6 Europe Histology/Cytology Market by Country
6.7 Europe Flow Cytometry Market by Country
6.8 Europe Mass Spectroscopy Market by Country
6.9 Europe Others Market by Country

Chapter 7. Europe Laboratory Developed Tests Market by Country
7.1 Germany Laboratory Developed Tests Market
7.1.1 Germany Laboratory Developed Tests Market by Application
7.1.2 Germany Laboratory Developed Tests Market by Technology
7.2 UK Laboratory Developed Tests Market
7.2.1 UK Laboratory Developed Tests Market by Application
7.2.2 UK Laboratory Developed Tests Market by Technology
7.3 France Laboratory Developed Tests Market
7.3.1 France Laboratory Developed Tests Market by Application
7.3.2 France Laboratory Developed Tests Market by Technology
7.4 Russia Laboratory Developed Tests Market
7.4.1 Russia Laboratory Developed Tests Market by Application
7.4.2 Russia Laboratory Developed Tests Market by Technology
7.5 Spain Laboratory Developed Tests Market
7.5.1 Spain Laboratory Developed Tests Market by Application
7.5.2 Spain Laboratory Developed Tests Market by Technology
7.6 Italy Laboratory Developed Tests Market
7.6.1 Italy Laboratory Developed Tests Market by Application
7.6.2 Italy Laboratory Developed Tests Market by Technology
7.7 Rest of Europe Laboratory Developed Tests Market
7.7.1 Rest of Europe Laboratory Developed Tests Market by Application
7.7.2 Rest of Europe Laboratory Developed Tests Market by Technology

Chapter 8. Company Profiles
8.1 Neogenomics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Guardant Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Quest Diagnostics Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.4.5 SWOT Analysis
8.5 Abbott Laboratories
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segment and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bio-Rad laboratories, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Eurofins Scientific SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 SWOT Analysis

TABLE 1 Europe Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 2 Europe Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 3 Europe Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 4 Europe Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 5 Europe Oncology Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Oncology Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Genetic Disorders/Inherited Disease Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Genetic Disorders/Inherited Disease Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Infectious & Parasitic Diseases Market by Country, 2020 - 2023, USD Million
TABLE 10 Europe Infectious & Parasitic Diseases Market by Country, 2024 - 2031, USD Million
TABLE 11 Europe Endocrine Market by Country, 2020 - 2023, USD Million
TABLE 12 Europe Endocrine Market by Country, 2024 - 2031, USD Million
TABLE 13 Europe Immunology Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Immunology Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Nutritional & Metabolic Disease Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Nutritional & Metabolic Disease Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Cardiology Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Cardiology Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Mental/Behavioral Disorder Market by Country, 2020 - 2023, USD Million
TABLE 20 Europe Mental/Behavioral Disorder Market by Country, 2024 - 2031, USD Million
TABLE 21 Europe Pediatrics-specific Testing Market by Country, 2020 - 2023, USD Million
TABLE 22 Europe Pediatrics-specific Testing Market by Country, 2024 - 2031, USD Million
TABLE 23 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 26 Europe Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 27 Europe Molecular Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 28 Europe Molecular Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 29 Europe Immunoassays Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe Immunoassays Market by Country, 2024 - 2031, USD Million
TABLE 31 Europe Hematology & Coagulation Market by Country, 2020 - 2023, USD Million
TABLE 32 Europe Hematology & Coagulation Market by Country, 2024 - 2031, USD Million
TABLE 33 Europe Microbiology Market by Country, 2020 - 2023, USD Million
TABLE 34 Europe Microbiology Market by Country, 2024 - 2031, USD Million
TABLE 35 Europe Clinical Chemistry Market by Country, 2020 - 2023, USD Million
TABLE 36 Europe Clinical Chemistry Market by Country, 2024 - 2031, USD Million
TABLE 37 Europe Histology/Cytology Market by Country, 2020 - 2023, USD Million
TABLE 38 Europe Histology/Cytology Market by Country, 2024 - 2031, USD Million
TABLE 39 Europe Flow Cytometry Market by Country, 2020 - 2023, USD Million
TABLE 40 Europe Flow Cytometry Market by Country, 2024 - 2031, USD Million
TABLE 41 Europe Mass Spectroscopy Market by Country, 2020 - 2023, USD Million
TABLE 42 Europe Mass Spectroscopy Market by Country, 2024 - 2031, USD Million
TABLE 43 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 44 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 45 Europe Laboratory Developed Tests Market by Country, 2020 - 2023, USD Million
TABLE 46 Europe Laboratory Developed Tests Market by Country, 2024 - 2031, USD Million
TABLE 47 Germany Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 48 Germany Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 49 Germany Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 50 Germany Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 51 Germany Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 52 Germany Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 53 UK Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 54 UK Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 55 UK Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 56 UK Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 57 UK Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 58 UK Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 59 France Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 60 France Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 61 France Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 62 France Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 63 France Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 64 France Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 65 Russia Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 66 Russia Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 67 Russia Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 68 Russia Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 69 Russia Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 70 Russia Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 71 Spain Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 72 Spain Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 73 Spain Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 74 Spain Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 75 Spain Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 76 Spain Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 77 Italy Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 78 Italy Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 79 Italy Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 80 Italy Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 81 Italy Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 82 Italy Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 83 Rest of Europe Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 84 Rest of Europe Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 85 Rest of Europe Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 86 Rest of Europe Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 87 Rest of Europe Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 88 Rest of Europe Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 89 Key Information – neogenomics, inc.
TABLE 90 Key Information – GUARDANT HEALTH, INC.
TABLE 91 Key Information – Qiagen N.V.
TABLE 92 Key information – Quest Diagnostics Incorporated
TABLE 93 Key Information – Abbott Laboratories
TABLE 94 Key Information – Siemens Healthineers AG
TABLE 95 key information – Illumina, Inc.
TABLE 96 Key Information – Bio-Rad Laboratories, Inc.
TABLE 97 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 98 Key Information – Eurofins Scientific SE

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Laboratory Developed Tests Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Laboratory Developed Tests Market
FIG 4 Porter’s Five Forces Analysis – Laboratory Developed Tests Market
FIG 5 Europe Laboratory Developed Tests Market share by Application, 2023
FIG 6 Europe Laboratory Developed Tests Market share by Application, 2031
FIG 7 Europe Laboratory Developed Tests Market by Application, 2020 - 2031, USD Million
FIG 8 Europe Laboratory Developed Tests Market share by Technology, 2023
FIG 9 Europe Laboratory Developed Tests Market share by Technology, 2031
FIG 10 Europe Laboratory Developed Tests Market by Technology, 2020 - 2031, USD Million
FIG 11 Europe Laboratory Developed Tests Market share by Country, 2023
FIG 12 Europe Laboratory Developed Tests Market share by Country, 2031
FIG 13 Europe Laboratory Developed Tests Market by Country, 2020 - 2031, USD Million
FIG 14 Swot Analysis: Neogenomics, Inc.
FIG 15 Swot Analysis: Guardant Health, Inc.
FIG 16 Recent strategies and developments: Qiagen N.V.
FIG 17 Swot Analysis: Qiagen N.V.
FIG 18 SWOT Analysis: Quest Diagnostics Incorporated
FIG 19 SWOT Analysis: Abbott Laboratories
FIG 20 SWOT Analysis: Siemens Healthineers AG
FIG 21 Swot Analysis: Illumina, Inc.
FIG 22 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 23 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 24 SWOT Analysis: Eurofins Scientific SEs